Mark G Foletta's Net Worth
$18.3 Million
Who is Mark G Foletta?
Mark G Foletta has an estimated net worth of $18.3 Million. This is based on reported shares across multiple companies, which include ENANTA PHARMACEUTICALS INC, DEXCOM INC, AMN HEALTHCARE SERVICES INC, Tocagen Inc, Regulus Therapeutics Inc., BIOCEPT INC, AMBIT BIOSCIENCES CORP, AMYLIN PHARMACEUTICALS INC, and ANADYS PHARMACEUTICALS INC.
SEC CIK
Mark G Foletta's CIK is 0001236389
Past Insider Trading and Trends
2006 was Mark G Foletta's most active year for acquiring shares with 27 total transactions. Mark G Foletta's most active month to acquire stocks was the month of April. 2006 was Mark G Foletta's most active year for disposing of shares, totalling 42 transactions. Mark G Foletta's most active month to dispose stocks was the month of July. 2012 saw Mark G Foletta paying a total of $2,018,627.60 for 231,703.3 shares, this is the most they've acquired in one year. In 2012 Mark G Foletta cashed out on 812,713.6 shares for a total of $21,324,356.27, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ENANTA PHARMACEUTICALS INC (ENTA) Snapshot price: $12.54
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
DEXCOM INC (DXCM) Snapshot price: $126.24
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -9.62% | -6.00K |
$117.00 | -$702,028.84 | 56.4K |
Scheduled
|
Jun 17 - Jun 18
| ||
Form 4
|
∞
| 2.97K |
—
|
—
| 2.97K |
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
| 62.4K |
May 18
| |||
Form 4
| +5.59% | 3.31K |
—
| $3.31 | 62.4K |
May 18
| |||
Form 4
| +8.22% | 1.12K |
—
| $1.12 | 14.77K |
May 19 - May 20
| |||
Form 4
| -3.82% | -500.00 |
$562.83 | -$281,415.78 | 12.6K |
Scheduled
|
Dec 1
| ||
Form 4
| -3.68% | -500.00 |
$626.32 | -$313,161.58 | 13.1K |
Scheduled
|
Nov 1
| ||
Form 4
| -3.55% | -500.00 |
$543.09 | -$271,546.70 | 13.6K |
Scheduled
|
Oct 1
| ||
Form 4
| +7.48% | 1.05K |
—
| $1.05 | 15.15K |
May 20 - May 21
| |||
Form 4
| -7.04% | -1.00K |
$341.32 | -$341,319.53 | 13.2K |
Scheduled
|
Nov 16
| ||
Form 4
| -6.58% | -1.00K |
$396.82 | -$396,819.42 | 14.2K |
Scheduled
|
Oct 15
| ||
Form 4
| -6.17% | -1.00K |
$394.14 | -$394,135.55 | 15.2K |
Scheduled
|
Sep 14
| ||
Form 4
| +5.52% | 895 |
—
| $0.90 | 17.1K |
May 21 - May 22
| |||
Form 4
| -7.07% | -1.00K |
$277.08 | -$277,079.31 | 13.15K |
Scheduled
|
Mar 3
| ||
Form 4
| -6.60% | -1.00K |
$237.84 | -$237,842.98 | 14.15K |
Scheduled
|
Feb 3
| ||
Form 4
| -6.19% | -1.00K |
$218.05 | -$218,052.89 | 15.15K |
Scheduled
|
Jan 3
| ||
Form 4
| -5.83% | -1.00K |
$227.59 | -$227,593.30 | 16.15K |
Scheduled
|
Dec 3
| ||
Form 4
| +17.82% | 3.06K |
—
| $3.06 | 20.2K |
May 30 - May 31
| |||
Form 4
| -7.09% | -1.00K |
$121.89 | -$121,894.52 | 13.1K |
Scheduled
|
May 15
| ||
Form 4
| -6.62% | -1.00K |
$118.98 | -$118,976.57 | 14.1K |
Scheduled
|
Apr 15
| ||
Form 4
| -6.21% | -1.00K |
$150.28 | -$150,278.97 | 15.1K |
Scheduled
|
Mar 15
| ||
Form 4
| -5.85% | -1.00K |
$148.72 | -$148,723.04 | 16.09K |
Scheduled
|
Feb 15
| ||
Form 4
| -5.53% | -1.00K |
$137.50 | -$137,503.00 | 17.09K |
Aug 24
| |||
Form 4/A
|
∞
| 4.05K |
—
| $4.05 | 4.05K |
Jun 1
| |||
Form 4
| +82.03% | 4.06K |
—
| $4.06 | 9.01K |
May 31
| |||
Form 4
| -15.98% | -2.50K |
$54.95 | -$137,385.75 | 13.14K |
Nov 27
| |||
Form 4
| +31.66% | 4.95K |
—
| $4.95 | 20.59K |
Jun 1
| |||
Form 4
| -10.32% | -1.80K |
$94.63 | -$170,325.00 | 15.64K |
Sep 7
| |||
Form 4
| +45.44% | 5.45K |
—
| $5.45 | 17.44K |
May 25
| |||
Form 4
| +63.79% | 4.67K |
—
| $4.67 | 11.99K |
Jun 3
| |||
Form 4
|
∞
| 7.32K |
—
| $7.32 | 7.32K |
Nov 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AMN HEALTHCARE SERVICES INC (AMN) Snapshot price: $74
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +19.61% | 1.68K |
—
|
—
| 10.25K |
Apr 19
| |||
Form 4
| +6.19% | 500 |
$56.90 | $28,450.00 | 8.57K |
Feb 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
$88.78 | -$129,441.24 | 8.07K |
Apr 21
| |||
Form 4
| -42.81% | -6.04K |
$84.35 | -$509,638.20 | 8.07K |
Apr 11
| |||
Form 4
| -2.08% | -300.00 |
—
|
—
| 14.12K |
Nov 15
| |||
Form 4
| +17.42% | 2.14K |
—
|
—
| 14.41K |
Apr 21
| |||
Form 4
| -16.92% | -2.50K |
$95.02 | -$237,540.00 | 12.28K |
Jun 11
| |||
Form 4
| +23.65% | 2.83K |
—
|
—
| 14.78K |
Apr 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 22
| |||
Form 4
| +32.15% | 2.91K |
—
|
—
| 11.95K |
Apr 17
| |||
Form 4
| +31.25% | 2.15K |
—
|
—
| 9.04K |
Apr 17
| |||
Form 4
| +95.46% | 3.37K |
—
|
—
| 6.89K |
Apr 18
| |||
Form 4
| -41.49% | -2.50K |
$47.03 | -$117,575.00 | 3.52K |
Nov 27
| |||
Form 4
| -19.93% | -1.50K |
$36.71 | -$55,057.50 | 6.03K |
Jun 13
| |||
Form 4
| +101.63% | 3.79K |
—
|
—
| 7.53K |
Apr 18 - Apr 19
| |||
Form 4
| -32.54% | -1.80K |
$37.81 | -$68,058.00 | 3.73K |
Dec 15
| |||
Form 4
|
∞
| 5.53K |
—
|
—
| 5.53K |
Apr 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 24
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Tocagen Inc (FBRX) Snapshot price: $0.5829
EVP & Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 4
| |||
Form 4
| +49.79% | 5K |
$4.30 | $21,475.00 | 15.04K |
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
| +50.00% | 2.5K |
$8.50 | $21,250.00 | 7.5K |
Dec 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
∞
| 5K |
$10.00 | $50,000.00 | 5K |
Apr 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Regulus Therapeutics Inc. (RGLS) Snapshot price: $1.38
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +719.10% | 71.91K |
$0.89 | $63,999.90 | 81.91K |
Dec 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
∞
| 10K |
$7.64 | $76,405.00 | 10K |
Aug 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||